BioNTech-Fosun Pharma (Europe; 95 percent efficacy), and AstraZeneca-Oxford (United Kingdom; 62 to 90 percent efficacy), providing 7.5 million shots from each company.
As of April 9, the government suspended orders of the AstraZeneca-Oxford jabs.
As of April 9, the government suspended orders of the AstraZeneca-Oxford jabs.